In our study, the results of human tissue-based IHC staining and QRT-PCR experiments well confirmed the biological value of F2R, HEY2, PXDN, RNF19A, SCG5, and DRAM1 in glioma. This evidence concerns the gene DRAM1 and central nervous system cancer.